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Mechanical thrombectomy (MT) is standard treatment for acute ischemic stroke (AIS) with
large-vessel occlusion within 6 h of symptom onset to treatment initiation (OTP). Recent tri-
als have extended the therapeutic time window for MT to within 24 h. However, MT treat-
ment remains low in remote areas. Nagasaki Prefecture, Japan has many inhabited islands
with no neurointerventionalists. Our hospital on the mainland is a regional hub for eight
island hospitals. We evaluated clinical outcomes of MT for patients with AIS on these islands
versus on the mainland.
Methods
During 2014–2019, we reviewed consecutive patients with AIS who received MT at our hos-
pital. Patients comprised the Islands group and Mainland group. Patient characteristics and
clinical outcomes were compared between groups.
Results
We included 91 patients (Islands group: 15 patients, Mainland group: 76 patients). Seven
patients (46.7%) in the Islands group versus 43 (56.6%) in the Mainland group achieved favor-
able outcomes. Successful recanalization was obtained in 11 patients (73.3%) on the islands
and 67 (88.2%) on the mainland. The median OTP time in the Islands was 365 min. In both the
Islands and Mainland groups, the OTP time and successful recanalization were associated
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with functional outcome. The modified Rankin Scale (mRS) score at 90 days�2 was obtained
in two patients and mRS = 3 in four patients among eight patients with OTP time >6 h.
Conclusions
Few patients with AIS on remote islands have received MT. Although patients who under-
went MT on the islands had longer OTP, the clinical outcomes were acceptable. OTP time on
remote islands must be shortened, as this is related to functional outcome. In some cases
with successful recanalization, a favorable outcome can still be obtained even after 6 h. Even
if OTP exceeds 6 h, it is desirable to appropriately select patients and actively perform MT.
Introduction
Mechanical thrombectomy (MT) has become a standard treatment for acute ischemic stroke
(AIS) with large-vessel occlusion (LVO) within 6 h of symptom onset to treatment initiation
(groin puncture) (OTP) [1–3]. Per results of the recent DEFUSE 3 (Endovascular Therapy Fol-
lowing Imaging Evaluation for Ischemic Stroke) and DAWN (DWI or CT Perfusion Assess-
ment with Clinical Mismatch in the Triage of Wake-Up and Late Presenting Strokes
Undergoing Neurointervention with Trevo) trials, the therapeutic time window for MT has
been extended to within 24 h of stroke onset for selected patients, based on imaging and clini-
cal examinations [3–5]. The results of these studies indicate that patients with ischemic brain
tissue that have not yet undergone infarction, or with penumbra, have improved functional
outcomes with MT. The number of patients receiving MT has increased [6, 7], accounting for
an estimated 6% of overall patients with AIS in 2018 in Japan [7]. However, MT treatment
remains low in rural and remote areas [6].
Nagasaki Prefecture has 51 inhabited islands, the largest number in Japan, comprising three
major island groups: Goto, Iki, and Tsushima (Fig 1). There are approximately 120,000 people
living on these islands. However, there are no neurointerventionalists on the islands [8]. Our
hospital, located on the mainland, serves as a regional hub for the island hospitals in Nagasaki
Prefecture as well as local hospitals on the mainland. For the management of patients with AIS
Fig 1. Geographic location of eight hospitals on islands and hub center in Nagasaki Prefecture, Kyushu, Japan.
Modified reprint from the Geospatial Information Authority of Japan under a CC BY license, with permission from
the Geospatial Information Authority, original copyright 2020.
https://doi.org/10.1371/journal.pone.0245082.g001
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on these islands, we have established a helicopter transportation and teleradiology system that
operates 24 h a day, 7 d/wk [8, 9].
The drip and ship (DS) method, whereby intravenous recombinant tissue plasminogen acti-
vator (IV rt-PA) is administered in a regional hospital, followed by patient transfer to a special-
ized stroke center, can facilitate early initiation of IV rt-PA [8, 10]. We previously reported
that DS thrombolytic therapy is performed in six of the eight hospitals on the three main
islands of Nagasaki [8, 9]. A nationwide study showed that the DS method could contribute to
an increase in the rate of IV rt-PA; this method is currently used for one in four patients
treated with IV rt-PA in the United States (US) [10]. For MT, several studies have also reported
the safety and effectiveness of the drip, ship, and retrieve approach in AIS [11, 12].
In the present study, we clarified the clinical outcomes of MT in patients with AIS on
islands who were transported to the hub center via the ship and retrieve (SR) method.
Methods
Patients
We reviewed the records of patients with AIS who underwent MT in our hub hospital between
January 2014 and December 2019. The inclusion criteria for MT were as follows: (1) OTP within
6 h of stroke onset, (2) no evidence of intracranial hemorrhage (ICH), (3) M1 segment of the mid-
dle cerebral artery (M1), M2 segment of the middle cerebral artery (M2), internal cerebral artery
(ICA), basilar artery (BA) on magnetic resonance (MR) angiography (MRA) or conventional
angiography with clinical deficits. For patients with 6–24 h OTP, MT was indicated if there was
an MR diffusion weighted imaging (DWI)-fluid-attenuated inversion recovery (FLAIR) mismatch
[13, 14], that is, an acute ischemic lesion on DWI without marked parenchymal hyperintensity on
FLAIR, in patients with M1, M2, ICA, or BA occlusion on MRA and clinical deficits. Patients
with a pre-morbid modified Rankin Scale (mRS) score 3–5 were excluded in the present study.
We divided the included patients into two groups. Patients in the “Islands” group were
transferred to our hospital from remote islands in Nagasaki Prefecture (Goto, Iki, and Tsu-
shima); the “Mainland” group consisted of patients who lived on the mainland (Fig 2). IV rt-
PA was performed following the criteria established by the Japan Stroke Society.
Patient demographic and baseline characteristics including age, sex, severity of neurological
deficit using the National Institutes of Health Stroke Scale (NIHSS) score, and stroke subtype
(according to TOAST [Trial of ORG 10172 in Acute Stroke Treatment] classification) [15]
Fig 2. Comparison of time metrics for patients with acute ischemic stroke in the Islands and Mainland groups.
The Mainland group was divided into two groups according to whether the patient was brought in directly (Direct) or
was transferred from another hospital (Transfer). CT, computed tomography, MRI, magnetic resonance imaging.
https://doi.org/10.1371/journal.pone.0245082.g002
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were compared between the two groups. We calculated the time between symptom onset and
arrival at our hospital, groin puncture, and reperfusion as the onset-to-door (OTD), OTP, and
onset-to-reperfusion (OTR) times, respectively. When the symptom onset time was unknown,
the last known normal time was defined as symptom onset. Occlusion of the M1, M2, ICA,
and BA was defined as LVO. Other variables included the reperfusion rate, based on the modi-
fied Thrombolysis in Cerebral Infarction (mTICI) grade [16], mRS score at 90 days after stroke
onset, and adverse event incidence. Hemorrhagic transformation (HT) was defined as any
ICH in the territory of the initial infarction during hospitalization and was confirmed using
multiple non-contrast head computed tomography (CT) or MR imaging (MRI). HT was cate-
gorized as a hemorrhagic infarction, type 1 or type 2 (HI-1 or HI-2) or parenchymal hema-
toma, type 1 or 2 (PH-1 or PH-2), according to definitions of the European Cooperative Acute
Stroke Study [17]. Symptomatic ICH was defined as neurological deterioration of 4+ points in
the NIHSS score within 24 h post procedure.
Ethics statement
This study was approved by the ethics committee of National Hospital Organization Nagasaki
Medical Center (approval number 28078). This was a retrospective study of medical records,
and the data were analyzed anonymously. All clinical investigations described in this study
were conducted in accordance with the principles expressed in the Declaration of Helsinki.
Teleradiology system and helicopter system
Our hospital, located on the mainland, serves as a hub hospital for eight hospitals on the
islands of Nagasaki Prefecture, Kyushu, Japan (Fig 1). The SYNAPSE Teleradiology system
(Fujifilm) connects our hospital with hospitals on the islands via Ajisai-net, which is the Japa-
nese Health Information Exchange in Nagasaki [8]. In addition, a new information and com-
munication technology (SYNAPSE ZERO; Fujifilm) using smart devices was introduced into
the teleradiology system [9]. In the Islands group, a physician conducted a neurological assess-
ment based on the NIHSS score at admission to an island hospital. Non-enhanced head CT
and MRI data of all patients with AIS on the islands were then transmitted via the teleradiology
system. The patients were transferred to our hub hospital using the SR method (Fig 2, Islands
group). Most patients with AIS who had LVO on the remote islands, without rt-PA and/or
MT treatment, were managed at hospitals on the islands; these cases were not included in this
study. The teleradiology system was not used in the Mainland group.
Our hospital uses three types of helicopter: helicopter emergency medical services (HEMS),
a Maritime Self-Defense Force (MSDF) helicopter, and a firefighting disaster prevention
(FDP) helicopter. Characteristics of each helicopter have been detailed in a previous report [8].
Endovascular treatment
Patients underwent MT using a suction catheter (Penumbra System; Penumbra, Alameda, CA,
USA) and/or stent retriever (Solitaire FR; Medtronic Neurovascular, Irvine, CA, USA and
Trevo ProVue; Stryker Neurovascular, Fremont, CA, USA) under local anesthesia. Other pro-
cedures included aggressive clot disruption with a microwire, balloon angioplasty, or carotid
stenting.
Evaluation of clinical outcomes
Based on the mRS score at 90 days after stroke onset, each patient’s clinical outcome was evalu-
ated as either “favorable” or “unfavorable” for scores� 2 or� 3, respectively.
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Statistical analysis
The aim of the present study was to summarize the current status of our helicopter transporta-
tion system; we therefore present inference statistics as descriptive ones [18] rather than infer-
ence of the larger population. A cumulative distribution function of time was used to evaluate
time-to-event variables. The effect of each factor on the distributional difference for each vari-
able of interest was described using p-values obtained from the normal asymptote of the
Mann–Whitney U test. Dependency between two binomials was described with a p-value
from the chi-square distribution of an appropriate degree of freedom. Analyses were per-
formed using IBM SPSS, version 25.0 (IBM Corp., Armonk, NY, USA), JMP 14.2 (SAS Insti-




Among 112 patients treated with MT, 21 patients with a pre-morbid modified Rankin Scale
(mRS) score 3–5 were excluded. Thus, 91 patients were included in this study, with 15 patients
in the Islands group and 76 patients in the Mainland group. In the Mainland group, 53 patients
were delivered to the hub hospital directly and 23 patients were transferred to the hub hospital
(Fig 2, Mainland group). IV rt-PA was performed in 8 patients (53.3%) in the Islands group
and 32 patients (42.1%) in the Mainland group (Table 1). The median patient age was 72.0
years in the Islands group and 78.0 years in the Mainland group (Table 1). Among the 91
Table 1. Baseline characteristics of patients treated with mechanical thrombectomy in the Islands and Mainland groups.
Total Islands Mainland p value
Number of patients 91 15 76
Male sex, n (%) 56 (61.5) 8 (53.3) 48 (63.2) 0.671
Age (years); median (IQR) 78.0 (66.0–82.0) 72.0 (63.5–83.0) 78.0 (67.8–82.0) 0.422
Hypertension, n (%) 58 (63.7) 9 (60.0) 49 (64.5) 0.972
Hyperlipidemia, n (%) 15 (16.5) 4 (26.7) 11 (14.5) 0.434
Diabetes mellitus, n (%) 19 (20.9) 2 (13.3) 17 (22.4) 0.729
Smoking, n (%) 12 (13.2) 1 (6.7) 11 (14.5) 0.682
Atrial fibrillation, n (%) 34 (37.4) 3 (20.0) 31 (40.8) 0.155
Helicopter transport, n (%) 32 (35.2) 15 17 (22.4) <0.001
Transfer, n (%) 38 (41.8) 15 23 (30.3) <0.001
Time from symptom onset to door at our hospital (OTD) (min); median (IQR) 166 (58–323) 321 (273–659) 135 (53–279) <0.001
Time from symptom onset to puncture (OTP) (min); median (IQR) 270 (162–373) 365 (317–728) 235 (169–361) 0.005
Time from symptom onset to recanalization (OTR) (min); median (IQR) 346 (274–440) 426 (396–861) 321 (261–426) 0.005
Initial NIHSS score; median (IQR) 17.0 (13.0–23.0)) 18.0 (14.5–23.0) 16.5 (13.0–23.0) 0.768
Occlusion site 0.789
ICA 21 5 17
M1 35 6 32
M2 24 4 18
BA 9 0 9
TOAST classification
Cardioembolism, n (%) 57 (62.6) 7 (46.7) 50 (65.8) 0.268
IQR, interquartile range; NIHSS, National Institutes of Health Stroke Scale; ICA, internal carotid artery; M1, M1 segment of the middle cerebral artery; M2, M2 segment
of the middle cerebral artery; BA, basilar artery; TOAST, Trial of ORG 10172 in Acute Stroke Treatment.
https://doi.org/10.1371/journal.pone.0245082.t001
PLOS ONE Helicopter transportation system on islands for patients undergoing mechanical thrombectomy
PLOS ONE | https://doi.org/10.1371/journal.pone.0245082 January 19, 2021 5 / 11
patients, there were no marked differences between the two groups regarding the initial
NIHSS score and distribution of stroke subtype.
All patients in the Islands group were transported via helicopter. Three types of helicopter
were used in the Islands group: HEMS (nine patients), an MSDF helicopter (five patients), and
an FDP helicopter (one patient) (Table 2). The time from arrival at hospitals on the islands to
arrival at the hub hospital was longer for patients who were transported with an MSDF/FDP
helicopter than with HEMS (the median of the respective groups was 272 min and 220 min for
MSDF/FDP and HEMS, respectively). The CT-Alberta Stroke Program Early CT score
(ASPECTS) decreased during patient transport from the islands to the hub hospital (Table 2).
In the Islands group, the OTD time was within 6 h in 10 patients (66.7%) and within 6–24 h in
5 patients (33.3%). Helicopter transport was used for 17 of 76 patients in the Mainland group
(Table 1), and all these patients were transported using HEMS. The median transport distance
from the islands to the hub hospital was 112 km (interquartile range [IQR]: 92.5–112), and the
transport distance by HEMS in the Mainland group was 22 km (IQR: 9.0–33.0). Fourteen
patients in Goto and one patient in Iki received MT; no patients in Tsushima underwent MT
(Table 2). Tsushima is the furthest island group from the mainland among the islands included
in this study. Among eight hospitals on the islands, patients receiving MT were limited to
those who were transported from only three hospitals on the islands. The median OTP time in
the Islands group was 365 min (IQR: 317–728). The OTD, OTP, and OTR times in the Islands
group were longer than those in the Mainland group; the median [IQR] of OTD, OTP, and
OTR times was 321 min [273–659], 365 min [317–728], and 426 min [396–861]; and 135 min
[53–279], 235 min [169–361], and 321 min [261–426] for the Islands and Mainland groups,
respectively.
In the Mainland group, the median OTP time in the Direct group was longer than that in
the Transfer group; the median [IQR] of OTP time was 215 min [140–300]; and 311 min
[280–377] for the Direct and Transfer groups, respectively (data not shown).
Table 2. Baseline characteristics of patients treated with ship and retrieve method on the Islands.
Number of patients 15
Distance (km); median (IQR) 112 (92.5–112)




Type of helicopter transport, n
HEMS 9
Firefighting disaster prevention helicopter 1
JMSDF helicopter 5
Time from symptom onset to door at island hospitals (min); median (IQR) 55 (30–99)
Time from island hospital door to door at hub hospital (min); median (IQR) 242 (215–273)
ASPECTS; median (IQR)
At island hospitals 9.0 (8.5–10.0)
At hub hospital 8.0 (7.0–8.0)
MRI DWI ASPECTS (at isolated island hospitals); median (IQR) 8.0 (7.0–8.8)
IQR, interquartile range; HEMS, helicopter emergency medical services; JMSDF, Japan Maritime Self-Defense Force;
CT, computed tomography; ASPECTS, Alberta Stroke Program Early CT score; MRI, magnetic resonance imaging;
DWI, diffusion-weighted imaging.
https://doi.org/10.1371/journal.pone.0245082.t002
PLOS ONE Helicopter transportation system on islands for patients undergoing mechanical thrombectomy
PLOS ONE | https://doi.org/10.1371/journal.pone.0245082 January 19, 2021 6 / 11
Functional outcomes
Symptomatic ICH was present in 1 of 15 patients (6.7%) in the Islands group and in 3 of 76
patients (3.9%) in the Mainland group (Table 3). In the Islands group, 7 of 15 patients (46.7%)
achieved favorable outcomes (mRS score�2) whereas 43 of 76 patients (56.6%) in the Main-
land group had favorable outcomes (Fig 3). The cumulative probability function of OTP strati-
fied by the mRS score at 90 days after stroke onset (Fig 4A) suggested consistency across the
Islands and Mainland groups with respect to shorter time of OTP being more likely to result in
a favorable functional outcome (defined in the Methods). In the Islands group, mRS score at
90 days�2 was found in five of seven patients with OTP time�6 h whereas two patients had
mRS�2 and four patients had mRS = 3 among eight patients with an OTP time>6 h
(Fig 4C).
Successful recanalization (mTICI�2b) was obtained in 11 of 15 patients (73.3%) on the
islands and 67 of 76 patients (88.2%) on the mainland (Table 3). Successful recanalization was
related to functional outcome in both the Islands and Mainland groups (Fig 4B). In the Islands
group, successful recanalization was obtained in both patients with mRS score�2 at 90 days
Table 3. Clinical results of patients treated with mechanical thrombectomy in the Islands and Mainland groups.
Total Islands Mainland P value
Number of patients 91 15 76
IV rt-PA, n (%) 40 (44.0) 8 (53.3) 32 (42.1) 0.606
Successful recanalization (mTICI 2b, 3), n (%) 78 (85.7) 11 (73.3) 67 (88.2) 0.273
sICH, n (%) 4 (4.4) 1 (6.7) 3 (3.9) 0.520
Hemorrhagic transformation, n (%) 27 (29.7) 6 (40.0) 21 (27.6) 0.516
HI-1 3 3 0
HI-2 14 3 11
PH-1 7 0 7
PH-2 3 0 3
mRS�2 at 90 days, n (%) 50 (54.9) 7 (46.7) 43 (56.6) 0.674
Mortality during admission, n (%) 5 (5.5) 2 (13.3) 3 (3.9) 0.189
IV rt-PA, intravenous recombinant tissue plasminogen activator; mTICI, modified Thrombolysis in Cerebral Infarction; sICH, symptomatic intracranial hemorrhage;
HI, hemorrhagic infarction; PH, parenchymal hemorrhage; mRS, modified Rankin Scale.
https://doi.org/10.1371/journal.pone.0245082.t003
Fig 3. Distribution of mRS score at 90 days in patients with acute ischemic stroke receiving mechanical
thrombectomy in the Islands and Mainland groups. In the Islands group, 7 of 15 patients (46.7%) achieved favorable
outcomes (mRS score�2) whereas 43 of 76 patients (56.6%) in the Mainland group had favorable outcomes. mRS,
modified Rankin Scale.
https://doi.org/10.1371/journal.pone.0245082.g003
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and with an OTP time >6 h. All four patients with unsuccessful recanalization (mTICI <2b)
in the Islands group had unfavorable outcomes (Fig 4B and 4C).
Discussion
During 2014–2019, only 15 patients on the remote islands of Nagasaki Prefecture underwent
MT, with no patients from Tsushima. The DR approach (IV rt-PA) was performed in 61
patients at six of eight hospitals on the islands during the same period [8, 9]. There were very
few patients with AIS on the islands who underwent MT in comparison with IV rt-PA. The
Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism (RESCUE)-Japan Proj-
ect reported that MT for AIS was performed in 9.8 patients per 100,000 population in Japan
during 2018 [20]. There are potentially more MT-adapted cases on the islands.
In the Islands group, 7 patients (46.7%) achieved favorable outcomes (mRS score�2)
whereas 43 (56.6%) in the Mainland group achieved favorable outcomes. The median OTR
time in the Islands group was 426 min (IQR: 396–861). The clinical results of function out-
come in the Islands group was acceptable, in comparison with the results of randomized con-
trol trials [21].
The median time from arrival at an island hospital to arrival at the hub hospital was 242
min (IQR: 215–273). Interhospital transfers can exceed 2 h even in high-volume primary
stroke centers [22]. Patients with AIS living on remote islands are first delivered to hospitals
on an island and are then transferred to the hub hospital via helicopter transport in selected
cases. A certain amount of time is required for transport because patients on the islands are
transported across the sea. In previous studies, the OTR time was found to affect the prognosis
of patients [23]. It is therefore important to reduce the time of delivery of patients with AIS to
a hub center. Another possibility is to create a staff position for a doctor who can perform MT
on remote islands, as some island hospitals have an angiography suite.
In the Mainland group, 30.3% of patients were secondarily transferred to our hub center
and underwent MT. The median OTP time in the Direct group was longer than that in the
Transfer group. Froehler et al. reported that secondary transfer leads to a considerable MT
treatment delay and less likelihood of functional outcome, as compared with patients who are
Fig 4. Functional outcomes and OTP time in the Islands and Mainland groups. (A) OTP time was related to
functional outcome in both the Islands and Mainland groups. Distribution of the mRS score at 90 days and successful
recanalization in the Islands and Mainland groups (B) Successful recanalization (modified Thrombolysis in Cerebral
Infarction [mTICI] grade�2b) was related to functional outcome in both the Islands and Mainland groups. (C)
Closed circle: successful recanalization. Open circle: unsuccessful recanalization (mTICI<2b). mRS�2 was found in
five of seven patients with an OTP time�360 min; two patients had mRS�2 and four had mRS = 3 among eight
patients with an OTP time>360 min. OTP, onset to puncture, mRS, modified Rankin Scale.
https://doi.org/10.1371/journal.pone.0245082.g004
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brought directly to a comprehensive stroke center [24]. Several clinical scales for predicting
LVO have been reported [25]. Use of these scales may increase the number of patients treated
directly and improve the functional outcome of MT.
In the Islands group, the proportion of patients achieving functional outcomes with an
OTP time�6 h was high; however, even beyond 6 h, mRS score 0–3 at 90 days was observed
in five of eight patients. This shows that even if the OTP time exceeds 6 h, the outcome can still
be good, even on isolated islands. On the basis of the results of recent trials, the therapeutic
time window for MT has been extended to within 24 h [4, 5]. DWI-FLAIR mismatch was asso-
ciated with a more moderate outcome in patients receiving MT within 24 h [14]. For MT,
time-based strategies are undergoing a transition to imaging-based strategies [26]. Thus, it is
necessary to inform island hospitals that the indications for MT are expanding. When per-
forming MT in patients on remote islands, we need to consider an imaging-based strategy. In
the near future, more patients living on isolated islands, including Tsushima, might be able to
receive MT.
Recently, robotic-assisted angiography has been applied in percutaneous coronary inter-
vention (PCI) [27] and the interventional management of extracranial vascular disease [28].
Remote tele-robotic-PCI with an operator located 20 miles from the patient has been success-
fully performed [29]. In the future, such robotic technology may dramatically change MT for
patients with AIS living in remote areas, freeing these patients from the need for helicopter
transport from areas where there are no neurointerventionalists, such as on Nagasaki’s islands.
Limitations
This study has several limitations. First, this was a retrospective, single-center study with a
small number of patients. Second, we did not include patients with LVO managed without
MT. Third, perfusion imaging was unavailable at our hospital and island hospitals in this
study. In the future, a larger prospective study will be needed, to evaluate differences between
AIS patients on remote islands and those on the mainland, treated with MT.
Conclusions
Few patients with AIS living on remote islands in Nagasaki Prefecture have received MT. In
our study, although patients who underwent MT in the island group had longer OTP, the clin-
ical outcomes were acceptable. The OTP time on remote islands must be shortened, as this fac-
tor is related to functional outcome. In some cases with successful recanalization, a favorable
outcome can still be obtained even after 6 h. Even if OTP exceeds 6 h, it is desirable to appro-
priately select patients and actively perform MT. We must increase the number of patients
with AIS who are able to receive MT on these remote islands.
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